Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer : A trial of the european organization for research and treatment of cancer gastrointestinal tract cancer cooperative group
- Author
- VANHOEFER, U; ROUGIER, P; BODENSTEIN, H; SCHMOLL, H.-J; BLEIBERG, H; NORDLINGER, B; COUVREUR, M.-L; BARON, B; WILS, J. A; WILKE, H; DUCREUX, M. P; LACAVE, A. J; VAN CUTSEM, E; PLANKER, M; DOS SANTOS, J. G; PIEDBOIS, P; PAILLOT, B
Centre Hospitalier Universitaire de Rouen, Rouen, France
Clinic for Hematology and Oncology, Martin-Luther-University, Halle, Germany
Department of Internal Medicine (Cancer Research), West German Cancer Center, University of Essen Medical School, Essen, Germany
Department of Internal Medicine, University Hospital Gasthuisberg, Leuven, Belgium
Henri Mondor Hospital, Creteil, France
Hôpital Ambroise Paré, Paris, France
Institut Gustave Roussy, Villejuif, France
Institut Jules Bordet and European Organization for Research and Treatment of Cancer Data Center, Brussels, Belgium
Instituto Portuges de Oncologia, Porto, Portugal
Klinikum Krefled, Krefeld, Germany
Klinikum Minden, Minden, United States
Servicio de Oncologia Medica, Hospital General de Asturias, Oviedo, Spain
St Laurentius Ziekenhuis, Roermond, Netherlands - Source
Journal of clinical oncology. 2000, Vol 18, Num 14, pp 2648-2657 ; ref : 39 ref
- ISSN
- 0732-183X
- Scientific domain
- Medical oncology
- Publisher
- Lippincott Williams & Wilkins, Baltimore, MD
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Anticancéreux Chimiothérapie Cisplatine Doxorubicine Efficacité traitement Essai clinique phase III Estomac Etoposide Fluoropyrimidine dérivé Fluorouracil Folinate de calcium Homme Méthotrexate Platine II Complexe Pyrimidine dérivé Stade avancé Tolérance Tumeur maligne Appareil digestif pathologie Estomac pathologie
- Keyword (en)
- Antineoplastic agent Chemotherapy Cisplatin Doxorubicin Treatment efficiency Phase III trial Stomach Etoposide Fluoropyrimidine derivatives Fluorouracil Calcium folinate Human Methotrexate Platinum II Complexes Pyrimidine derivatives Advanced stage Tolerance Malignant tumor Digestive diseases Gastric disease
- Keyword (es)
- Anticanceroso Quimioterapia Cisplatino Doxorubicina Eficacia tratamiento Ensayo clínico fase III Estómago Etopósido Fluoropirimidina derivado Fluorouracilo Folinato cálcico Hombre Metotrexato Platino II Complejo Pirimidina derivado Estadio avanzado Tolerancia Tumor maligno Aparato digestivo patología Estómago patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R02 Chemotherapy
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B13 Gastroenterology. Liver. Pancreas. Abdomen / 002B13B Stomach. Duodenum. Small intestine. Colon. Rectum. Anus / 002B13B01 Tumors
- Discipline
- Gastroenterology. Liver. Pancreas. Abdomen Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 1448547
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1200/JCO.2000.18.14.2648 
https://dx.doi.org/10.1200/JCO.2000.18.14.2648
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:27:\"10.1200\/JCO.2000.18.14.2648\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:356:\"Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer : A trial of the european organization for research and treatment of cancer gastrointestinal tract cancer cooperative group\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:2:\"18\";s:8:\"\u0000*\u0000issue\";s:2:\"14\";s:8:\"\u0000*\u0000spage\";s:4:\"2648\";s:8:\"\u0000*\u0000epage\";s:4:\"2657\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"VANHOEFER\";s:10:\"\u0000*\u0000aufirst\";s:1:\"U\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:10:\"ROUGIER, P\";i:1;s:13:\"BODENSTEIN, H\";i:2;s:13:\"SCHMOLL, H.-J\";i:3;s:11:\"BLEIBERG, H\";i:4;s:13:\"NORDLINGER, B\";i:5;s:14:\"COUVREUR, M.-L\";i:6;s:8:\"BARON, B\";i:7;s:10:\"WILS, J. A\";i:8;s:8:\"WILKE, H\";i:9;s:13:\"DUCREUX, M. P\";i:10;s:12:\"LACAVE, A. J\";i:11;s:13:\"VAN CUTSEM, E\";i:12;s:10:\"PLANKER, M\";i:13;s:16:\"DOS SANTOS, J. G\";i:14;s:11:\"PIEDBOIS, P\";i:15;s:10:\"PAILLOT, B\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:356:\"Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer : A trial of the european organization for research and treatment of cancer gastrointestinal tract cancer cooperative group\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:27:\"10.1200\/JCO.2000.18.14.2648\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:356:\"Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer : A trial of the european organization for research and treatment of cancer gastrointestinal tract cancer cooperative group\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:2:\"18\";s:8:\"\u0000*\u0000issue\";s:2:\"14\";s:8:\"\u0000*\u0000spage\";s:4:\"2648\";s:8:\"\u0000*\u0000epage\";s:4:\"2657\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"VANHOEFER\";s:10:\"\u0000*\u0000aufirst\";s:1:\"U\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:10:\"ROUGIER, P\";i:1;s:13:\"BODENSTEIN, H\";i:2;s:13:\"SCHMOLL, H.-J\";i:3;s:11:\"BLEIBERG, H\";i:4;s:13:\"NORDLINGER, B\";i:5;s:14:\"COUVREUR, M.-L\";i:6;s:8:\"BARON, B\";i:7;s:10:\"WILS, J. A\";i:8;s:8:\"WILKE, H\";i:9;s:13:\"DUCREUX, M. P\";i:10;s:12:\"LACAVE, A. J\";i:11;s:13:\"VAN CUTSEM, E\";i:12;s:10:\"PLANKER, M\";i:13;s:16:\"DOS SANTOS, J. G\";i:14;s:11:\"PIEDBOIS, P\";i:15;s:10:\"PAILLOT, B\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:356:\"Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer : A trial of the european organization for research and treatment of cancer gastrointestinal tract cancer cooperative group\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:27:\"10.1200\/JCO.2000.18.14.2648\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:27:\"10.1200\/JCO.2000.18.14.2648\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:356:\"Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer : A trial of the european organization for research and treatment of cancer gastrointestinal tract cancer cooperative group\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:2:\"18\";s:8:\"\u0000*\u0000issue\";s:2:\"14\";s:8:\"\u0000*\u0000spage\";s:4:\"2648\";s:8:\"\u0000*\u0000epage\";s:4:\"2657\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"VANHOEFER\";s:10:\"\u0000*\u0000aufirst\";s:1:\"U\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:10:\"ROUGIER, P\";i:1;s:13:\"BODENSTEIN, H\";i:2;s:13:\"SCHMOLL, H.-J\";i:3;s:11:\"BLEIBERG, H\";i:4;s:13:\"NORDLINGER, B\";i:5;s:14:\"COUVREUR, M.-L\";i:6;s:8:\"BARON, B\";i:7;s:10:\"WILS, J. A\";i:8;s:8:\"WILKE, H\";i:9;s:13:\"DUCREUX, M. P\";i:10;s:12:\"LACAVE, A. J\";i:11;s:13:\"VAN CUTSEM, E\";i:12;s:10:\"PLANKER, M\";i:13;s:16:\"DOS SANTOS, J. G\";i:14;s:11:\"PIEDBOIS, P\";i:15;s:10:\"PAILLOT, B\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:356:\"Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer : A trial of the european organization for research and treatment of cancer gastrointestinal tract cancer cooperative group\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:27:\"10.1200\/JCO.2000.18.14.2648\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:356:\"Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer : A trial of the european organization for research and treatment of cancer gastrointestinal tract cancer cooperative group\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:2:\"18\";s:8:\"\u0000*\u0000issue\";s:2:\"14\";s:8:\"\u0000*\u0000spage\";s:4:\"2648\";s:8:\"\u0000*\u0000epage\";s:4:\"2657\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"VANHOEFER\";s:10:\"\u0000*\u0000aufirst\";s:1:\"U\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:10:\"ROUGIER, P\";i:1;s:13:\"BODENSTEIN, H\";i:2;s:13:\"SCHMOLL, H.-J\";i:3;s:11:\"BLEIBERG, H\";i:4;s:13:\"NORDLINGER, B\";i:5;s:14:\"COUVREUR, M.-L\";i:6;s:8:\"BARON, B\";i:7;s:10:\"WILS, J. A\";i:8;s:8:\"WILKE, H\";i:9;s:13:\"DUCREUX, M. P\";i:10;s:12:\"LACAVE, A. J\";i:11;s:13:\"VAN CUTSEM, E\";i:12;s:10:\"PLANKER, M\";i:13;s:16:\"DOS SANTOS, J. G\";i:14;s:11:\"PIEDBOIS, P\";i:15;s:10:\"PAILLOT, B\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:356:\"Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer : A trial of the european organization for research and treatment of cancer gastrointestinal tract cancer cooperative group\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
